Table 2 Baseline characteristics of type 2 diabetic patients with abdominal obesity according to PvuII phenotype

Age, years

56.2 ± 7.8

57.1 ± 7.5

56.3 ± 7.6

Male / female, n

18 / 13

9 / 7

2 / 2

Duration of diabetes, years (median, IQR)

5.0 (2.0–9.0)

4.0 (1.0–4.5)

3.5 (2.5–4.5)

 Diet only

2

1

0

 Oral agents

22

12

4

 Insulin

3

1

0

 Insulin + oral agents

4

2

0

Waistline, cm

90.9 ± 5.6

92.8 ± 6.8

90.3 ± 3.8

BMI, kg/m²

25.3 ± 2.7

25.4 ± 2.5

25.5 ± 4.6

Glucose, mmol/L

7.98 ± 1.89

7.52 ± 2.39

8.17 ± 2.30

Insulin, uIU/mL (median, IQR)

11.35 (9.59–15.56)

11.95 (9.45–18.10)

10.58 (8.05–11.55)

HOMA-IR (median, IQR)

4.31 (3.19–5.68)

4.21 (2.85–6.16)

3.61 (2.56–4.68)

TG, mmol/L

1.22 ± 0.35

1.16 ± 0.29

0.78 ± 0.35

TC, mmol/L

4.83 ± 0.98

4.76 ± 0.82

4.47 ± 0.80

HDL-C, mmol/L

1.22 ± 0.29

1.27 ± 0.28

1.11 ± 0.13